Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells.

BMC Cancer · 2013 · PMC3635914 · PMID 23343191

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

P276-00 and doxorubicin alone caused significant suppression of tumor growth, while the combination of the two drugs showed highly significant reduction in the mean tumor weight (Figure 5 A).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.